|1.||Chen, Yujia: 1 article (12/2012)|
|2.||Heng, Ling Zhi: 1 article (12/2012)|
|3.||Tan, Thiam Chye: 1 article (12/2012)|
|4.||Expert Board of Polish Gynecological Society,: 1 article (04/2009)|
|5.||Lyte, Peter: 1 article (09/2006)|
|6.||Garay, Michelle: 1 article (09/2006)|
|7.||Liebel, Frank: 1 article (09/2006)|
|8.||Babad, Jeffrey: 1 article (09/2006)|
|9.||Southall, Michael D: 1 article (09/2006)|
|10.||Seidman, Larry S: 1 article (12/2005)|
11/01/1999 - "Butoconazole 1-BSR rapidly relieved the signs and symptoms of vulvovaginal candidiasis. "
04/01/1988 - "Patient acceptance of a new, compact, prefilled disposable vaginal applicator was tested in an open study in which 2% butoconazole cream was used for the treatment of vulvovaginal candidiasis. "
11/01/1999 - "Butoconazole nitrate 2% for vulvovaginal candidiasis. "
05/01/1988 - "[Butoconazole nitrate in vulvovaginal candidiasis. "
07/04/1986 - "Butoconazole for vulvovaginal candidiasis."
01/01/1993 - "Efficacy of butoconazole nitrate in the treatment of vulvo-vaginal candidiasis compared with clotrimazol and isoconasol."
12/01/2012 - "Treatment of recurrent vulvo-vaginal candidiasis with sustained-released butoconazole pessary."
08/01/1985 - "In a single blind trial, a three day course of butoconazole nitrate cream was compared with a seven day course of miconazole nitrate cream, both applied intravaginally, in treating vaginal candidiasis. "
08/01/1985 - "Butoconazole and miconazole in treating vaginal candidiasis."
07/08/1996 - "Most responders (64%) agreed that pharmacists could provide, without a prescription, a 3-day course of a vaginal cream containing 2% butoconazole for vaginal candidiasis in nonpregnant women and a rectal suppository containing steroids for hemorrhoid sufferers (61%). "
01/01/2000 - "In this study, we show that fluconazole-resistant (MIC > 64 microg/mL) blood stream isolates of Candida albicans and Candida glabrata obtained from cancer patients were cross-resistant to the root drugs miconazole, clotrimazole, and tioconazole (found in several over-the-counter products), but remained susceptible to butoconazole. "
12/01/2005 - "Vulvovaginal pruritus and vulvovaginal burning were the most common drug-related adverse events attributed to butoconazole. "
09/01/2006 - "The anti-inflammatory activities of eight anti-fungal agents (butoconazole, ciclopirox olamine, fluconazole, miconazole nitrate, sertaconazole nitrate, terconazole, tioconazole and ketoconazole) were compared in a number of preclinical models of dermal inflammation and pruritus. "
02/01/1990 - "A 54-year-old woman with a 19-year history of rheumatoid arthritis developed life-threatening thrombocytopenia one week after beginning butoconazole therapy for a vaginal yeast infection. "
10/01/1984 - "Eight days after treatment completion, Candida albicans was absent in vaginal cultures of 95% of patients receiving butoconazole and of 91% of patients receiving clotrimazole; 30 days after treatment completion, 80% of patients receiving butoconazole were free of the fungal infection; the corresponding number for clotrimazole was 74%. "
|4.||Vaginal Creams, Foams, and Jellies (Vaginal Tablet)